Stockscreener 앱 받기
7.76
0.51%
-0.04
시간 외 거래:
7.73
-0.03
-0.39%
전일 마감가:
$7.80
열려 있는:
$7.75
하루 거래량:
108.99K
Relative Volume:
0.72
시가총액:
$281.63M
수익:
$8.98M
순이익/손실:
$-31.39M
주가수익비율:
-5.791
EPS:
-1.34
순현금흐름:
$-24.83M
1주 성능:
-1.52%
1개월 성능:
+5.29%
6개월 성능:
+36.62%
1년 성능:
+11.82%
1일 변동 폭
$7.5729
$8.1499
1주일 범위
$7.40
$8.26
52주 변동 폭
$3.76
$8.95
프로파운드 메디컬 Stock (PROF) Company Profile
명칭
Profound Medical Corp
전화
647-476-1350
주소
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
PROF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
7.76 | 283.09M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
프로파운드 메디컬 Stock (PROF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-23 | 개시 | Lake Street | Buy |
| 2024-07-16 | 업그레이드 | Stifel | Hold → Buy |
| 2023-11-28 | 개시 | Stifel | Hold |
| 2023-08-04 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-15 | 개시 | Jefferies | Buy |
모두보기
프로파운드 메디컬 주식(PROF)의 최신 뉴스
Profound Medical to Engage Investors at February Life Sciences Conferences - TipRanks
Profound Medical Announces Upcoming Investor Events - Investing News Network
How To Trade (PRN) (PRN:CA) - Stock Traders Daily
Johns Hopkins Medicine Initiates Use of Profound Medical’s TULSA-PRO System - Medical Product Outsourcing
(PROF) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
(PRN) On The My Stocks Page (PRN:CA) - Stock Traders Daily
Profound Medical raises US$6.45 million in Canadian private placement - MSN
(PRN) Daily Stock Insights (PRN:CA) - Stock Traders Daily
Investors in Profound Medical (TSE:PRN) have unfortunately lost 67% over the last five years - Yahoo Finance
Profound Medical upsizes private placement to raise US$6.45 million - MSN
Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock? - Yahoo Finance
Profound Medical (PROF) Introduces TULSA-PRO at Mount Sinai Hosp - GuruFocus
Long Term Trading Analysis for (PRN) (PRN:CA) - Stock Traders Daily
Profound Medical Expands TULSA-PRO Use at Mount Sinai - TipRanks
AI-guided, incision-free prostate treatment debuts at Mount Sinai - Stock Titan
Profound Medical (TSE:PRN) Hits New 1-Year HighTime to Buy? - MarketBeat
Profound Medical Exceeds 2025 TULSA-PRO Installation Target and Grows Sales Pipeline - The Globe and Mail
Objective long/short (PRN) Report (PRN:CA) - Stock Traders Daily
Profound Medical Corp Surpasses 2025 TULSA-PRO® Installation Goal - TradingView — Track All Markets
Profound Surpasses 2025 TULSA-PRO Installed Base Goal - 富途资讯
Profound Medical (PROF) Surpasses Installation Goal with TULSA-P - GuruFocus
Profound Surpasses 2025 TULSA-PRO® Installed Base Goal - Investing News Network
How Profound Medical Corp. stock performs during Fed tightening cyclesJuly 2025 Closing Moves & AI Powered Buy and Sell Recommendations - Улправда
Will Profound Medical Corp. stock reach all time highs in 2025Portfolio Gains Report & Low Risk High Win Rate Picks - Улправда
Why Profound Medical Corp. stock attracts high net worth investors2025 Buyback Activity & AI Powered Market Entry Ideas - Улправда
Why Profound Medical Corp. stock remains on buy listsOptions Play & Fast Gain Swing Trade Alerts - Улправда
Profound Medical (NASDAQ:PROF) Trading 5.8% Higher – Here’s What Happened - Defense World
Profound Medical (NASDAQ:PROF) Trading 5.8% HigherHere's What Happened - MarketBeat
Can Profound Medical Corp. stock deliver sustainable ROEStock Split Announcements & Make Confident Moves With Forecasting Models - Улправда
Profound Medical (PROF) Sees Price Target Boost by Lake Street | - GuruFocus
Profound Medical stock price target raised to $12 by Lake Street - Investing.com Canada
Profound Medical Corp Launches TULSA-PRO at Johns Hopkins - TradingView — Track All Markets
Profound Medical Reclaims Canadian Distribution Rights for TULSA-PRO® - MSN
Profound Medical’s TULSA-PRO Marks First Commercial Case at Johns Hopkins - TipRanks
Profound Medical (PROF) Marks Milestone at Johns Hopkins Hospita - GuruFocus
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case - The Manila Times
Incision-free prostate cancer procedure debuts at Johns Hopkins - Stock Titan
(PRN) Long Term Investment Analysis (PRN:CA) - Stock Traders Daily
Profound Medical announces pricing of up to $40 million financing - MSN
Highs Report: How BRZE stock reacts to job market dataPortfolio Risk Report & Daily Growth Stock Investment Tips - moha.gov.vn
Trading (PRN) With Integrated Risk Controls (PRN:CA) - Stock Traders Daily
Profound Medical Secures $36 Million to Expand Commercialization of AI-Powered Prostate Treatment - citybuzz -
Sentiment Recap: How Profound Medical Corp stock valuations compare to rivalsSell Signal & Trade Opportunity Analysis - moha.gov.vn
Profound Medical Corp closes private placement - Medical Buyer
Profound Medical Signs Subscription Agreement With Canadian Investors - TradingView — Track All Markets
Insider Spends US$139k Buying More Shares In Profound Medical - Yahoo Finance
프로파운드 메디컬 (PROF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
0.96%
자본화:
|
볼륨(24시간):